Cipher Surgical, established in 2010, is a prominent player in the Health Care and Medical Devices industries. Known for its slogan, "CONTINUOUS VISION," the company specializes in enhancing laparoscopic procedures through its innovative OpClear platform. This technology is designed to provide the surgical team with uninterrupted intra-abdominal vision, thus maintaining surgical flow, reducing errors, and shortening operating times.
The OpClear platform excels by using automated CO2 flow and an on-demand saline lens wash, eliminating the frequent need for scope removal due to visual obstructions like blood or particles. This technological breakthrough is crucial for successful surgeries, offering a consistent vision throughout procedures and addressing key challenges in the surgical process.
Headquartered in the United States, Cipher Surgical's last funding round was a Series A investment on March 4, 2018, spearheaded by Trend Investment Group. This financial backing underscores strong investor confidence in Cipher Surgical's potential for continued innovation in the medical device sector.